Akorn (AKRX +5%) trades higher after announcing that it purchased 3 off-patent branded...


Akorn (AKRX +5%) trades higher after announcing that it purchased 3 off-patent branded injectables from Denmark's Lundbeck for an upfront payment of $45M and a milestone payment of $15M after 3 years. The firm's CEO says the products will add to its niche portfolio of hospital-based injectables.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs